Fundamental Analysis of BANCO MACRO SA-ADR(NYSE:BMA) stock

Fundamental Rating

Taking everything into account, BMA scores 3 out of 10 in our fundamental rating. BMA was compared to 412 industry peers in the Banks industry. BMA has a bad profitability rating. Also its financial health evaluation is rather negative. BMA is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past 5 years BMA has always been profitable.

The reported operating cash flow has been mixed in the past 5 years: BMA reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of BMA (8.92%) is better than 100.00% of its industry peers.

Looking at the Return On Equity, with a value of 29.32%, BMA belongs to the top of the industry, outperforming 99.27% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	8.92%
ROE	29.32%
ROIC	N/A

ROA(3y)4.51%

ROA(5y)4.21%

ROE(3y)16.17%

ROE(5y)16.7%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BMA has a worse Profit Margin (19.14%) than 69.90% of its industry peers.

BMA's Profit Margin has declined in the last couple of years.

BMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	19.14%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y5.35%

PM growth 5Y-6.18%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, BMA has about the same amount of shares outstanding.

The number of shares outstanding for BMA has been reduced compared to 5 years ago.

BMA has a worse debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 0.21 indicates that BMA is not too dependend on debt financing.

BMA's Debt to Equity ratio of 0.21 is in line compared to the rest of the industry. BMA outperforms 54.13% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1096.39%, which is quite impressive.

The Earnings Per Share has been growing by 107.65% on average over the past years. This is a very strong growth

Looking at the last year, BMA shows a very strong growth in Revenue. The Revenue has grown by 431.94%.

BMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 119.85% yearly.

EPS 1Y (TTM)1096.39%

EPS 3Y151.76%

EPS 5Y107.65%

EPS growth Q2Q2358.46%

Revenue 1Y (TTM)431.94%

Revenue growth 3Y139.02%

Revenue growth 5Y119.85%

Revenue growth Q2Q891.35%

3.2 Future

Based on estimates for the next years, BMA will show a very strong growth in Earnings Per Share. The EPS will grow by 101.49% on average per year.

The Revenue is expected to grow by 77.55% on average over the next years. This is a very strong growth

EPS Next Y278.84%

EPS Next 2Y101.49%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year120.53%

Revenue Next 2Y77.55%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BMA's earnings are expected to grow with 101.49% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y101.49%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BMA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BANCO MACRO SA-ADR

NYSE:BMA (5/3/2024, 7:04:00 PM)

After market: 60.05 -0.17 (-0.28%)

60.22

+4.11 (+7.32%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.85B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	8.92%
ROE	29.32%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	19.14%
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.47

Health

		Industry Rank	Sector Rank
Debt/Equity	0.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)1096.39%

EPS 3Y151.76%

EPS 5Y

EPS growth Q2Q

EPS Next Y278.84%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)431.94%

Revenue growth 3Y139.02%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

BANCO MACRO SA-ADR (BMA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens